{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:02:50Z","timestamp":1792515770806,"version":"4.5.0"},"reference-count":173,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004863","name":"Zhejiang Chinese Medical University","doi-asserted-by":"publisher","award":["2024JKZKTS09"],"award-info":[{"award-number":["2024JKZKTS09"]}],"id":[{"id":"10.13039\/501100004863","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LY23H280008"],"award-info":[{"award-number":["LY23H280008"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bcp.2025.117208","type":"journal-article","created":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T12:52:42Z","timestamp":1754139162000},"page":"117208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"P3","title":["Targeting AKT to treat liver disease: Opportunities and challenges"],"prefix":"10.1016","volume":"242","author":[{"given":"Zeping","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyuan","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2025.117208_b0005","article-title":"Targeting AKT\/PKB to improve treatment outcomes for solid tumors","volume":"819\u2013820","author":"Iida","year":"2020","journal-title":"Mutat. Res."},{"issue":"4","key":"10.1016\/j.bcp.2025.117208_b0010","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1002\/jcp.29229","article-title":"Protein kinase Akt2\/PKB\u03b2 is involved in blastomere proliferation of preimplantation mouse embryos","volume":"235","author":"Fiorenza","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"8015","key":"10.1016\/j.bcp.2025.117208_b0015","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41586-024-07465-2","article-title":"Acquisition of epithelial plasticity in human chronic liver disease","volume":"630","author":"Gribben","year":"2024","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.bcp.2025.117208_b0020","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/s41419-021-04418-9","article-title":"Matrix stiffness modulates hepatic stellate cell activation into tumor-promoting myofibroblasts via E2F3-dependent signaling and regulates malignant progression","volume":"12","author":"Liu","year":"2021","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bcp.2025.117208_b0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261619","article-title":"Impact of acute decompensation on the prognosis of patients with hepatocellular carcinoma","volume":"17","author":"Kondo","year":"2022","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bcp.2025.117208_b0030","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.bcp.2025.117208_b0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22041794","article-title":"Targeting Akt in hepatocellular carcinoma and its tumor microenvironment","volume":"22","author":"Mroweh","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2025.117208_b0040","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jhep.2022.10.037","article-title":"Using mouse liver cancer models based on somatic genome editing to predict immune checkpoint inhibitor responses","volume":"78","author":"Yuen","year":"2023","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117208_b0045","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117208_b0050","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/cld.1061","article-title":"Global epidemiology of chronic liver disease","volume":"17","author":"Cheemerla","year":"2021","journal-title":"Clin. Liver Dis. (hoboken)"},{"issue":"7","key":"10.1016\/j.bcp.2025.117208_b0055","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1158\/0008-5472.CAN-22-3169","article-title":"HBx-induced HSPA8 stimulates HBV replication and suppresses ferroptosis to support liver cancer progression","volume":"83","author":"Wang","year":"2023","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.bcp.2025.117208_b0060","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13304","article-title":"Intracellular antibody targeting HBx suppresses invasion and metastasis in hepatitis B virus-related hepatocarcinogenesis via protein phosphatase 2A-B56\u03b3-mediated dephosphorylation of protein kinase B","volume":"55","author":"Che","year":"2022","journal-title":"Cell Prolif."},{"issue":"2","key":"10.1016\/j.bcp.2025.117208_b0065","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2021.7683","article-title":"Diagnosis and treatment of alcohol-associated liver disease: a review","volume":"326","author":"Singal","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.bcp.2025.117208_b0070","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-pathmechdis-031521-030435","article-title":"Recent advances in understanding of pathogenesis of alcohol-associated liver disease","volume":"18","author":"Wu","year":"2023","journal-title":"Annu. Rev. Pathol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117208_b0075","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1002\/fsn3.2133","article-title":"Intracellular ethanol-mediated oxidation and apoptosis in HepG2\/CYP2E1 cells impaired by two active peptides from seahorse (Hippocampus kuda bleeler) protein hydrolysates via the Nrf2\/HO-1 and akt pathways","volume":"9","author":"Qian","year":"2021","journal-title":"Food Sci. Nutr."},{"issue":"2","key":"10.1016\/j.bcp.2025.117208_b0080","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.31050","article-title":"Lipotoxic hepatocyte-derived exosomal MicroRNA 192-5p activates macrophages through rictor\/Akt\/forkhead box transcription factor O1 signaling in nonalcoholic fatty liver disease","volume":"72","author":"Liu","year":"2020","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.bcp.2025.117208_b0085","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1021\/acs.chemrestox.2c00100","article-title":"BML-257, a small molecule that protects against drug-induced liver injury in Zebrafish","volume":"35","author":"Jagtap","year":"2022","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bcp.2025.117208_b0090","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.972397","article-title":"Hydroxychloroquine attenuates autoimmune hepatitis by suppressing the interaction of GRK2 with PI3K in T lymphocytes","volume":"13","author":"Jin","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"22","key":"10.1016\/j.bcp.2025.117208_b0095","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1056\/NEJMoa2214131","article-title":"Capivasertib in hormone receptor-positive advanced breast cancer","volume":"388","author":"Turner","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.bcp.2025.117208_b0100","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.2174\/0113892010291042240130171709","article-title":"RNA-based therapeutics: past, present and Future prospects, challenges in cancer treatment","volume":"25","author":"Goel","year":"2024","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.bcp.2025.117208_b0105","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.80148","article-title":"PH domain-mediated autoinhibition and oncogenic activation of Akt","volume":"11","author":"Bae","year":"2022","journal-title":"Elife"},{"issue":"33","key":"10.1016\/j.bcp.2025.117208_b0110","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2101496118","article-title":"Structure of autoinhibited Akt1 reveals mechanism of PIP(3)-mediated activation","volume":"118","author":"Truebestein","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"678","key":"10.1016\/j.bcp.2025.117208_b0115","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abe4509","article-title":"mTORC2 controls the activity of PKC and Akt by phosphorylating a conserved TOR interaction motif","volume":"14","author":"Baffi","year":"2021","journal-title":"Sci. Signal."},{"issue":"1","key":"10.1016\/j.bcp.2025.117208_b0120","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0888-7543(88)90114-0","article-title":"The AKT1 proto-oncogene maps to human chromosome 14, band q32","volume":"2","author":"Staal","year":"1988","journal-title":"Genomics"},{"issue":"19","key":"10.1016\/j.bcp.2025.117208_b0125","doi-asserted-by":"crossref","first-page":"9267","DOI":"10.1073\/pnas.89.19.9267","article-title":"AKT2, a putative oncogene encoding a member of a subfamily of protein-serine\/threonine kinases, is amplified in human ovarian carcinomas","volume":"89","author":"Cheng","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"31","key":"10.1016\/j.bcp.2025.117208_b0130","doi-asserted-by":"crossref","first-page":"21528","DOI":"10.1074\/jbc.274.31.21528","article-title":"Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines","volume":"274","author":"Nakatani","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.bcp.2025.117208_b0135","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1080\/17460441.2024.2384467","article-title":"The value of protein allostery in rational anticancer drug design: an update","volume":"19","author":"Nussinov","year":"2024","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.bcp.2025.117208_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216288","article-title":"DUSP2 recruits CSNK2A1 to suppress AKT1-mediated apoptosis resistance under hypoxic microenvironment in pancreatic cancer","volume":"568","author":"Zhang","year":"2023","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.bcp.2025.117208_b0145","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13764","article-title":"Reversine ameliorates hallmarks of cellular senescence in human skeletal myoblasts via reactivation of autophagy","volume":"22","author":"Rajabian","year":"2023","journal-title":"Aging Cell"},{"issue":"4","key":"10.1016\/j.bcp.2025.117208_b0150","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1093\/brain\/awac376","article-title":"The genomic landscape across 474 surgically accessible epileptogenic human brain lesions","volume":"146","author":"L\u00f3pez-Rivera","year":"2023","journal-title":"Brain"},{"issue":"6694","key":"10.1016\/j.bcp.2025.117208_b0155","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1126\/science.adk1005","article-title":"Food perception promotes phosphorylation of MFFS131 and mitochondrial fragmentation in liver","volume":"384","author":"Henschke","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.bcp.2025.117208_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.155120","article-title":"Mevalonate pathway orchestrates insulin signaling via RAB14 geranylgeranylation-mediated phosphorylation of AKT to regulate hepatic glucose metabolism","volume":"128","author":"Wang","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.bcp.2025.117208_b0165","unstructured":"M.B. Murphrey, L. Quaim, N. Rahimi, and M.A. Varacallo, Biochemistry, Epidermal Growth Factor Receptor, in StatPearls. 2025, StatPearls Publishing Copyright \u00a9 2025, StatPearls Publishing LLC.: Treasure Island (FL) ineligible companies."},{"issue":"16","key":"10.1016\/j.bcp.2025.117208_b0170","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612665","article-title":"The Role of PIK3R1 in Metabolic Function and Insulin Sensitivity","volume":"24","author":"Tsay","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2025.117208_b0175","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1038\/s41467-022-28910-8","article-title":"S6K1-mediated phosphorylation of PDK1 impairs AKT kinase activity and oncogenic functions","volume":"13","author":"Jiang","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2025.117208_b0180","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s13578-023-01185-2","article-title":"NUAK1 coordinates growth factor-dependent activation of mTORC2 and Akt signaling","volume":"13","author":"Palma","year":"2023","journal-title":"Cell Biosci."},{"issue":"22","key":"10.1016\/j.bcp.2025.117208_b0185","doi-asserted-by":"crossref","DOI":"10.1172\/JCI174415","article-title":"TSC\/mTORC1 mediates mTORC2\/AKT1 signaling in c-MYC-induced murine hepatocarcinogenesis via centromere protein M","volume":"134","author":"Zhou","year":"2024","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.bcp.2025.117208_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021176","article-title":"Liver regeneration and immunity: a tale to tell","volume":"24","author":"Di-Iacovo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.bcp.2025.117208_b0195","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/s41556-020-00596-4","article-title":"Phosphatidylinositol-3-OH kinase signalling is spatially organized at endosomal compartments by microtubule-associated protein 4","volume":"22","author":"Thapa","year":"2020","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117208_b0200","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1124\/molpharm.121.000310","article-title":"mTOR regulation of AGC kinases: new twist to an old tail","volume":"101","author":"Baffi","year":"2022","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117208_b0205","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12964-018-0278-2","article-title":"Reduced menin expression impairs rapamycin effects as evidenced by an increase in mTORC2 signaling and cell migration","volume":"16","author":"Razmara","year":"2018","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bcp.2025.117208_b0210","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1089558","article-title":"Hydroxy-\u03b1-sanshool isolated from Zanthoxylum bungeanum Maxim. has antidiabetic effects on high-fat-fed and streptozotocin-treated mice via increasing glycogen synthesis by regulation of PI3K\/Akt\/GSK-3\u03b2\/GS signaling","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117208_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.stemcr.2024.11.001","article-title":"Glycogen synthase kinase-3 inhibition and insulin enhance proliferation and inhibit maturation of human iPSC-derived cardiomyocytes via TCF and FOXO signaling","volume":"20","author":"Yuan","year":"2025","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.bcp.2025.117208_b0220","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.omtn.2021.05.018","article-title":"circPTEN suppresses colorectal cancer progression through regulating PTEN\/AKT pathway","volume":"26","author":"Li","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"1","key":"10.1016\/j.bcp.2025.117208_b0225","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12964-024-01592-z","article-title":"TRAF6-mediated ubiquitination of AKT in the nucleus is a critical event underlying the desensitization of G protein-coupled receptors","volume":"22","author":"Wu","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bcp.2025.117208_b0230","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.1047823","article-title":"The sooner, the better: ROS, kinases and nutrients at the onset of the damage response in Drosophila","volume":"10","author":"Serras","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bcp.2025.117208_b0235","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2024.1408949","article-title":"Multi-faceted regulation of CREB family transcription factors","volume":"17","author":"Chowdhury","year":"2024","journal-title":"Front. Mol. Neurosci."},{"issue":"3","key":"10.1016\/j.bcp.2025.117208_b0240","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1096\/fj.201902319RRR","article-title":"Corylin, a flavonoid derived from Psoralea Fructus, induces osteoblastic differentiation via estrogen and Wnt\/beta-catenin signaling pathways","volume":"34","author":"Yu","year":"2020","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.bcp.2025.117208_b0245","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41420-022-01291-z","article-title":"Coal dust nanoparticles induced pulmonary fibrosis by promoting inflammation and epithelial-mesenchymal transition via the NF-\u03baB\/NLRP3 pathway driven by IGF1\/ROS-mediated AKT\/GSK3\u03b2 signals","volume":"8","author":"Zhang","year":"2022","journal-title":"Cell Death Discov"},{"issue":"18","key":"10.1016\/j.bcp.2025.117208_b0250","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1042\/CS20220572","article-title":"Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways","volume":"136","author":"Badmus","year":"2022","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.bcp.2025.117208_b0255","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.822333","article-title":"Akt: a potential Drug Target for Metabolic Syndrome","volume":"13","author":"Miao","year":"2022","journal-title":"Front. Physiol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117208_b0260","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.1002\/j.2040-4603.2023.tb00269.x","article-title":"Insulin Regulation of Hepatic Lipid Homeostasis","volume":"13","author":"Uehara","year":"2023","journal-title":"Compr. Physiol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117208_b0265","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s10555-023-10156-5","article-title":"Regulation and targeting of SREBP-1 in hepatocellular carcinoma","volume":"43","author":"Su","year":"2024","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bcp.2025.117208_b0270","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.85293","article-title":"Fat body-specific reduction of CTPS alleviates HFD-induced obesity","volume":"12","author":"Liu","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.bcp.2025.117208_b0275","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.trsl.2024.01.005","article-title":"Active AKT2 stimulation of SREBP1\/SCD1-mediated lipid metabolism boosts hepatosteatosis and cancer","volume":"268","author":"Huang","year":"2024","journal-title":"Transl. Res."},{"key":"10.1016\/j.bcp.2025.117208_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107791","article-title":"Peroxisome proliferator-activated receptors in the pathogenesis and therapies of liver fibrosis","volume":"222","author":"Han","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2025.117208_b0285","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.635175","article-title":"Sphingolipids as a Culprit of Mitochondrial Dysfunction in Insulin Resistance and Type 2 Diabetes","volume":"12","author":"Roszczyc-Owsiejczuk","year":"2021","journal-title":"Front. Endocrinol. (lausanne)"},{"issue":"10\u201312","key":"10.1016\/j.bcp.2025.117208_b0290","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1089\/ars.2022.0206","article-title":"Oxidative stress, transfer RNA metabolism, and protein synthesis","volume":"40","author":"Akiyama","year":"2024","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bcp.2025.117208_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102468","article-title":"Fibroblast growth factor 7 alleviates myocardial infarction by improving oxidative stress via PI3K\u03b1\/AKT-mediated regulation of Nrf2 and HXK2","volume":"56","author":"Mei","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.bcp.2025.117208_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120111","article-title":"Nrf2\/Keap1\/ARE signaling: Towards specific regulation","volume":"291","author":"Ulasov","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2025.117208_b0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115992","article-title":"4-octyl itaconate protects against oxidative stress-induced liver injury by activating the Nrf2\/Sirt3 pathway through AKT and ERK1\/2 phosphorylation","volume":"220","author":"Hu","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2025.117208_b0310","article-title":"The Keap1\/Nrf2 Signaling Pathway in the Thyroid-2020 Update","volume":"9","author":"Thanas","year":"2020","journal-title":"Antioxidants (basel)"},{"issue":"21","key":"10.1016\/j.bcp.2025.117208_b0315","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242115525","article-title":"Artemisia annua Extract Attenuate Doxorubicin-Induced Hepatic Injury via PI-3K\/Akt\/Nrf-2-Mediated Signaling Pathway in Rats","volume":"24","author":"El-Said","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117208_b0320","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.722734","article-title":"Costunolide-Induced Apoptosis via Promoting the Reactive Oxygen Species and Inhibiting AKT\/GSK3\u03b2 Pathway and Activating Autophagy in Gastric Cancer","volume":"9","author":"Xu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117208_b0325","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bcp.2025.117208_b0330","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ajpath.2019.09.011","article-title":"Ferroptosis affects the progression of nonalcoholic steatohepatitis via the modulation of lipid peroxidation-mediated cell death in mice","volume":"190","author":"Qi","year":"2020","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117208_b0335","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41420-023-01746-x","article-title":"Targeting AKT induced Ferroptosis through FTO\/YTHDF2-dependent GPX4 m6A methylation up-regulating and degradating in colorectal cancer","volume":"9","author":"Zhang","year":"2023","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.bcp.2025.117208_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117438","article-title":"Angong Niuhuang Wan inhibit ferroptosis on ischemic and hemorrhagic stroke by activating PPAR\u03b3\/AKT\/GPX4 pathway","volume":"321","author":"Bai","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"9","key":"10.1016\/j.bcp.2025.117208_b0345","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/s41556-024-01429-4","article-title":"Mitochondria and cell death","volume":"26","author":"Glover","year":"2024","journal-title":"Nat. Cell Biol."},{"issue":"7","key":"10.1016\/j.bcp.2025.117208_b0350","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13071543","article-title":"Apoptosis-inducing TNF superfamily ligands for cancer therapy","volume":"13","author":"Diaz Arguello","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bcp.2025.117208_b0355","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1293130","article-title":"A review on the mechanisms underlying the antitumor effects of natural products by targeting the endoplasmic reticulum stress apoptosis pathway","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"22","key":"10.1016\/j.bcp.2025.117208_b0360","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228563","article-title":"A new twist in protein kinase B\/Akt signaling: role of altered cancer cell metabolism in Akt-mediated therapy resistance","volume":"21","author":"G\u00f6tting","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.bcp.2025.117208_b0365","doi-asserted-by":"crossref","DOI":"10.3390\/cells9081843","article-title":"Brain-specific Serine-47 modification of cytochrome c regulates cytochrome c oxidase activity attenuating ROS production and cell death: implications for ischemia\/reperfusion injury and Akt signaling","volume":"9","author":"Kalpage","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.bcp.2025.117208_b0370","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12967-021-02954-8","article-title":"SRPK1\/AKT axis promotes oxaliplatin-induced anti-apoptosis via NF-\u03baB activation in colon cancer","volume":"19","author":"Huang","year":"2021","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.bcp.2025.117208_b0375","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/hh1301.092506","article-title":"Phosphatidylinositol 3-kinase\/Akt signaling controls endothelial cell sensitivity to Fas-mediated apoptosis via regulation of FLICE-inhibitory protein (FLIP)","volume":"89","author":"Suhara","year":"2001","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.bcp.2025.117208_b0380","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1074\/jbc.M304736200","article-title":"The Akt-regulated forkhead transcription factor FOXO3a controls endothelial cell viability through modulation of the caspase-8 inhibitor FLIP","volume":"279","author":"Skurk","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.bcp.2025.117208_b0385","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/s41419-021-04419-8","article-title":"Underlying mechanisms of glucocorticoid-induced \u03b2-cell death and dysfunction: a new role for glycogen synthase kinase 3","volume":"12","author":"Delangre","year":"2021","journal-title":"Cell Death Dis."},{"issue":"13","key":"10.1016\/j.bcp.2025.117208_b0390","doi-asserted-by":"crossref","first-page":"7200","DOI":"10.1073\/pnas.121173298","article-title":"Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor","volume":"98","author":"Lin","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bcp.2025.117208_b0395","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.990874","article-title":"Akt isoforms in the immune system","volume":"13","author":"Guerau-de-Arellano","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2025.117208_b0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2020.111801","article-title":"H(2)S exposure-induced oxidative stress promotes LPS-mediated hepatocyte autophagy through the PI3K\/AKT\/TOR pathway","volume":"209","author":"Guo","year":"2021","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"1","key":"10.1016\/j.bcp.2025.117208_b0405","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s11658-023-00462-9","article-title":"The NLRP3 inflammasome: contributions to inflammation-related diseases","volume":"28","author":"Chen","year":"2023","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.bcp.2025.117208_b0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115246","article-title":"Bifurcation of signalling in human innate immune pathways to NF-kB and IRF family activation","volume":"205","author":"Kusiak","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117208_b0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2023.113683","article-title":"NLRP3 Inflammasome: a key contributor to the inflammation formation","volume":"174","author":"Zhang","year":"2023","journal-title":"Food Chem. Toxicol."},{"issue":"8","key":"10.1016\/j.bcp.2025.117208_b0420","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.4049\/jimmunol.2000649","article-title":"AKT regulates NLRP3 inflammasome activation by phosphorylating NLRP3 Serine 5","volume":"205","author":"Zhao","year":"2020","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117208_b0425","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1002\/med.21842","article-title":"The immunosuppressive activity of artemisinin-type drugs towards inflammatory and autoimmune diseases","volume":"41","author":"Efferth","year":"2021","journal-title":"Med. Res. Rev."},{"issue":"1","key":"10.1016\/j.bcp.2025.117208_b0430","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13058-023-01684-7","article-title":"Enhancement of PD-L1-attenuated CAR-T cell function through breast cancer-associated fibroblasts-derived IL-6 signaling via STAT3\/AKT pathways","volume":"25","author":"Chuangchot","year":"2023","journal-title":"Breast Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117208_b0435","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12964-018-0268-4","article-title":"Activation of the JAK\/STAT3 and PI3K\/AKT pathways are crucial for IL-6 trans-signaling-mediated pro-inflammatory response in human vascular endothelial cells","volume":"16","author":"Zegeye","year":"2018","journal-title":"Cell Commun. Signal"},{"issue":"13","key":"10.1016\/j.bcp.2025.117208_b0440","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136777","article-title":"Liver disease: induction, progression, immunological mechanisms, and therapeutic interventions","volume":"22","author":"Neshat","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2025.117208_b0445","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bcp.2025.117208_b0450","article-title":"The role of sirtuin1 in liver injury: molecular mechanisms and novel therapeutic target","volume":"12","author":"Wang","year":"2024","journal-title":"PeerJ"},{"issue":"6","key":"10.1016\/j.bcp.2025.117208_b0455","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/liv.14478","article-title":"What's in a name? Renaming 'NAFLD' to 'MAFLD'","volume":"40","author":"Fouad","year":"2020","journal-title":"Liver Int."},{"issue":"5","key":"10.1016\/j.bcp.2025.117208_b0460","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/s41401-022-00860-3","article-title":"Updates on novel pharmacotherapeutics for the treatment of nonalcoholic steatohepatitis","volume":"43","author":"Yang","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"issue":"6","key":"10.1016\/j.bcp.2025.117208_b0465","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/apt.17158","article-title":"Review article: the epidemiologic burden of non-alcoholic fatty liver disease across the world","volume":"56","author":"Henry","year":"2022","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.bcp.2025.117208_b0470","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.cmet.2024.04.006","article-title":"Hepatic selective insulin resistance at the intersection of insulin signaling and metabolic dysfunction-associated steatotic liver disease","volume":"36","author":"Bo","year":"2024","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.bcp.2025.117208_b0475","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","article-title":"Reprogramming of fatty acid metabolism in cancer","volume":"122","author":"Koundouros","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.bcp.2025.117208_b0480","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1042\/BCJ20190570","article-title":"Regulation of basal expression of hepatic PEPCK and G6Pase by AKT2","volume":"477","author":"He","year":"2020","journal-title":"Biochem. J"},{"issue":"23","key":"10.1016\/j.bcp.2025.117208_b0485","doi-asserted-by":"crossref","first-page":"7873","DOI":"10.1007\/s00018-021-03993-6","article-title":"Role of Akt isoforms in neuronal insulin signaling and resistance","volume":"78","author":"Sharma","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.bcp.2025.117208_b0490","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s11154-021-09652-2","article-title":"AKT ISOFORMS-AS160-GLUT4: the defining axis of insulin resistance","volume":"22","author":"Sharma","year":"2021","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.bcp.2025.117208_b0495","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.2147\/RMHP.S416592","article-title":"Genetic Variations of AKT1 are Associated with Risk Screening for Non-Alcoholic Fatty Liver Disease","volume":"16","author":"Ding","year":"2023","journal-title":"Risk Manag Healthc Policy"},{"issue":"1","key":"10.1016\/j.bcp.2025.117208_b0500","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41423-020-00579-3","article-title":"Immunological mechanisms and therapeutic targets of fatty liver diseases","volume":"18","author":"Wang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"7","key":"10.1016\/j.bcp.2025.117208_b0505","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/s12276-024-01261-8","article-title":"NLRP3 inflammasome: a key player in the pathogenesis of life-style disorders","volume":"56","author":"Ramachandran","year":"2024","journal-title":"Exp. Mol. Med."},{"issue":"9","key":"10.1016\/j.bcp.2025.117208_b0510","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1039\/D0FO02736G","article-title":"Hesperetin ameliorates hepatic oxidative stress and inflammation via the PI3K\/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD","volume":"12","author":"Li","year":"2021","journal-title":"Food Funct."},{"issue":"2","key":"10.1016\/j.bcp.2025.117208_b0515","first-page":"246","article-title":"Effect of aerobic exercise on AKT\/GSK3\u03b2 mediated hepatocyte apoptosis in nonalcoholic fatty liver disease","volume":"52","author":"Wang","year":"2023","journal-title":"Wei Sheng Yan Jiu"},{"issue":"5","key":"10.1016\/j.bcp.2025.117208_b0520","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1002\/hep.31583","article-title":"Reducing the global burden of alcohol-associated liver disease: a blueprint for action","volume":"73","author":"Asrani","year":"2021","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.bcp.2025.117208_b0525","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jceh.2022.09.001","article-title":"Epidemiology and disease burden of alcohol associated liver disease","volume":"13","author":"Aslam","year":"2023","journal-title":"J. Clin. Exp. Hepatol."},{"issue":"11","key":"10.1016\/j.bcp.2025.117208_b0530","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115717","article-title":"Pathophysiological aspects of alcohol metabolism in the liver","volume":"22","author":"Hyun","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117208_b0535","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1215333","article-title":"NLRP3: a new therapeutic target in alcoholic liver disease","volume":"14","author":"Brahadeeswaran","year":"2023","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117208_b0540","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22042139","article-title":"The purinergic P2X7 receptor-NLRP3 inflammasome pathway: a new target in alcoholic liver disease?","volume":"22","author":"Le Dar\u00e9","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117208_b0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115753","article-title":"CD73 mitigates hepatic damage in alcoholic steatohepatitis by regulating PI3K\/AKT-mediated hepatocyte pyroptosis","volume":"215","author":"Zhu","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117208_b0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101538","article-title":"SIRT1 agonism modulates cardiac NLRP3 inflammasome through pyruvate dehydrogenase during ischemia and reperfusion","volume":"34","author":"Han","year":"2020","journal-title":"Redox Biol."},{"issue":"11","key":"10.1016\/j.bcp.2025.117208_b0555","doi-asserted-by":"crossref","DOI":"10.3390\/cells8111337","article-title":"Akt1 and Akt2 isoforms play distinct roles in regulating the development of inflammation and fibrosis associated with alcoholic liver disease","volume":"8","author":"Reyes-Gordillo","year":"2019","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.bcp.2025.117208_b0560","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10565-021-09624-x","article-title":"Protecting mitochondria via inhibiting VDAC1 oligomerization alleviates ferroptosis in acetaminophen-induced acute liver injury","volume":"38","author":"Niu","year":"2022","journal-title":"Cell Biol. Toxicol."},{"issue":"8","key":"10.1016\/j.bcp.2025.117208_b0565","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1080\/10937404.2023.2261848","article-title":"Drug induced liver injury - a 2023 update","volume":"26","author":"Allison","year":"2023","journal-title":"J. Toxicol. Environ. Health B Crit. Rev."},{"issue":"3","key":"10.1016\/j.bcp.2025.117208_b0570","article-title":"Oxidative stress in Drug-induced liver injury (DILI): from mechanisms to biomarkers for use in clinical practice","volume":"10","author":"Villanueva-Paz","year":"2021","journal-title":"Antioxidants (basel)"},{"issue":"5","key":"10.1016\/j.bcp.2025.117208_b0575","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.chom.2023.04.002","article-title":"Liberation of daidzein by gut microbial \u03b2-galactosidase suppresses acetaminophen-induced hepatotoxicity in mice","volume":"31","author":"Zeng","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.bcp.2025.117208_b0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155142","article-title":"Drug-induced liver injury and anti-hepatotoxic effect of herbal compounds: a metabolic mechanism perspective","volume":"122","author":"Rani","year":"2024","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.bcp.2025.117208_b0585","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010500","article-title":"Hepatocellular carcinoma in chronic viral hepatitis: where do we stand?","volume":"23","author":"Russo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117208_b0590","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1322892","article-title":"Role of hepatitis B virus non-structural protein HBx on HBV replication, interferon signaling, and hepatocarcinogenesis","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bcp.2025.117208_b0595","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13578-019-0328-5","article-title":"Steroid receptor coactivator 3 inhibits hepatitis B virus gene expression through activating Akt signaling to prevent HNF4\u03b1 nuclear translocation","volume":"9","author":"Li","year":"2019","journal-title":"Cell Biosci."},{"key":"10.1016\/j.bcp.2025.117208_b0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122412","article-title":"Akt1 is involved in HCV release by promoting endoplasmic reticulum-to-endosome transition of infectious virions","volume":"338","author":"Lee","year":"2024","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.bcp.2025.117208_b0605","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/mco2.15","article-title":"De novo lipogenesis is elicited dramatically in human hepatocellular carcinoma especially in hepatitis C virus-induced hepatocellular carcinoma","volume":"1","author":"Li","year":"2020","journal-title":"MedComm"},{"issue":"Pt A","key":"10.1016\/j.bcp.2025.117208_b0610","article-title":"TPN10475 alleviates concanavalin A-induced autoimmune hepatitis by limiting T cell development and function through inhibition of PI3K-AKT pathway","volume":"125","author":"Wang","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"10","key":"10.1016\/j.bcp.2025.117208_b0615","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1136\/gutjnl-2020-322362","article-title":"Recent advances in clinical practice: epidemiology of autoimmune liver diseases","volume":"70","author":"Trivedi","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.bcp.2025.117208_b0620","article-title":"Celastrol alleviates autoimmune hepatitis through the PI3K\/AKT signaling pathway based on network pharmacology and experiments","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117208_b0625","article-title":"CCN1 Promotes inflammation by inducing IL-6 production via \u03b16\u03b21\/PI3K\/Akt\/NF-\u03baB pathway in autoimmune hepatitis","volume":"13","author":"Jiang","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117208_b0630","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13045-021-01137-8","article-title":"Targeting Akt in cancer for precision therapy","volume":"14","author":"Hua","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"16","key":"10.1016\/j.bcp.2025.117208_b0635","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2025.117208_b0640","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2025.117208_b0645","doi-asserted-by":"crossref","unstructured":"Y. Wang, J. Xiao, T.O. Suzek, J. Zhang, J. Wang, and S.H. Bryant, PubChem: a public information system for analyzing bioactivities of small molecules. Nucleic Acids Res, 2009. 37(Web Server issue): p. W623-33.","DOI":"10.1093\/nar\/gkp456"},{"key":"10.1016\/j.bcp.2025.117208_b0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120752","article-title":"Naringenin: a potential flavonoid phytochemical for cancer therapy","volume":"305","author":"Motallebi","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2025.117208_b0655","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2015.04.003","article-title":"Naringenin suppresses TPA-induced tumor invasion by suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells","volume":"235","author":"Yen","year":"2015","journal-title":"Chem. Biol. Interact."},{"issue":"9","key":"10.1016\/j.bcp.2025.117208_b0660","doi-asserted-by":"crossref","DOI":"10.3390\/nu15092232","article-title":"6-Shogaol, an active component of ginger, inhibits p300 histone acetyltransferase activity and attenuates the development of pressure-overload-induced heart failure","volume":"15","author":"Kawase","year":"2023","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.bcp.2025.117208_b0665","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.1002\/fsn3.4129","article-title":"Review of the anticancer properties of 6-shogaol: Mechanisms of action in cancer cells and future research opportunities","volume":"12","author":"Figueroa-Gonz\u00e1lez","year":"2024","journal-title":"Food Sci. Nutr."},{"issue":"1","key":"10.1016\/j.bcp.2025.117208_b0670","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.bbrc.2016.12.114","article-title":"Scutellarin suppresses migration and invasion of human hepatocellular carcinoma by inhibiting the STAT3\/Girdin\/Akt activity","volume":"483","author":"Ke","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.bcp.2025.117208_b0675","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/jsfa.10152","article-title":"Resveratrol: a review of plant sources, synthesis, stability, modification and food application","volume":"100","author":"Tian","year":"2020","journal-title":"J. Sci. Food Agric."},{"issue":"1","key":"10.1016\/j.bcp.2025.117208_b0680","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11010221","article-title":"Resveratrol and its role in the management of B-cell malignancies-a recent update","volume":"11","author":"Gupta","year":"2023","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.bcp.2025.117208_b0685","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28062597","article-title":"Structure-based profiling of potential phytomolecules with AKT1 a key cancer drug target","volume":"28","author":"Mirza","year":"2023","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bcp.2025.117208_b0690","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/s41467-022-29655-0","article-title":"Distinct resistance mechanisms arise to allosteric vs. ATP-competitive AKT inhibitors","volume":"13","author":"Savill","year":"2022","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.bcp.2025.117208_b0695","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1158\/1535-7163.MCT-13-1043","article-title":"Inhibition of Akt reverses the acquired resistance to sorafenib by switching protective autophagy to autophagic cell death in hepatocellular carcinoma","volume":"13","author":"Zhai","year":"2014","journal-title":"Mol. Cancer Ther."},{"issue":"4","key":"10.1016\/j.bcp.2025.117208_b0700","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/s41401-021-00729-x","article-title":"MK2206 attenuates atherosclerosis by inhibiting lipid accumulation, cell migration, proliferation, and inflammation","volume":"43","author":"Tang","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"issue":"8","key":"10.1016\/j.bcp.2025.117208_b0705","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14081882","article-title":"Combined Targeting of AKT and mTOR Inhibits Tumor Formation of EpCAM(+) and CD90(+) Human Hepatocellular Carcinoma Cells in an Orthotopic Mouse Model","volume":"14","author":"Moustafa","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.bcp.2025.117208_b0710","doi-asserted-by":"crossref","first-page":"10672","DOI":"10.18632\/aging.202845","article-title":"NET1 promotes HCC growth and metastasis in vitro and in vivo via activating the Akt signaling pathway","volume":"13","author":"Chen","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bcp.2025.117208_b0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107059","article-title":"Properties of FDA-approved small molecule protein kinase inhibitors: a 2024 update","volume":"200","author":"Roskoski","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"7","key":"10.1016\/j.bcp.2025.117208_b0720","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41419-020-02741-1","article-title":"A combination of AZD5363 and FH5363 induces lethal autophagy in transformed hepatocytes","volume":"11","author":"Patra","year":"2020","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.bcp.2025.117208_b0725","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1124\/dmd.122.001175","article-title":"The absolute bioavailability and absorption, metabolism, and excretion of ipatasertib, a potent and highly selective protein kinase B (Akt) inhibitor","volume":"51","author":"Takahashi","year":"2023","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.bcp.2025.117208_b0730","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jcph.1941","article-title":"Pharmacokinetics of ipatasertib in subjects with hepatic impairment using 2 methods of classification of hepatic function","volume":"62","author":"Sane","year":"2022","journal-title":"J. Clin. Pharmacol."},{"issue":"36","key":"10.1016\/j.bcp.2025.117208_b0735","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1200\/JCO.20.02672","article-title":"Systemic therapy for advanced hepatocellular carcinoma: ASCO guideline","volume":"38","author":"Gordan","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"24","key":"10.1016\/j.bcp.2025.117208_b0740","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232416206","article-title":"Effect of novel AKT inhibitor vevorisertib as single agent and in combination with sorafenib on hepatocellular carcinoma in a cirrhotic rat model","volume":"23","author":"Kurma","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.bcp.2025.117208_b0745","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1002\/cncr.34733","article-title":"Phase 1b study of pan-AKT inhibitor vevorisertib alone or with paclitaxel or fulvestrant in PIK3CA\/AKT\/PTEN-mutated advanced solid tumors","volume":"129","author":"Pant","year":"2023","journal-title":"Cancer"},{"issue":"19","key":"10.1016\/j.bcp.2025.117208_b0750","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911502","article-title":"miRNA: A promising therapeutic target in cancer","volume":"23","author":"Menon","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2025.117208_b0755","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.apsb.2021.06.009","article-title":"miR-7\/TGF-\u03b22 axis sustains acidic tumor microenvironment-induced lung cancer metastasis","volume":"12","author":"Su","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.bcp.2025.117208_b0760","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41419-021-04491-0","article-title":"MiRNA-124-3p.1 sensitizes hepatocellular carcinoma cells to sorafenib by regulating FOXO3a by targeting AKT2 and SIRT1","volume":"13","author":"Dong","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2025.117208_b0765","first-page":"e1820","article-title":"Regulation of microRNA by circular RNA. Wiley Interdiscip Rev","author":"Singh","year":"2023","journal-title":"RNA"},{"key":"10.1016\/j.bcp.2025.117208_b0770","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1365032","article-title":"Circular RNA PRKCI (hsa_circ_0067934): a potential target in the pathogenesis of human malignancies","volume":"14","author":"Qiu","year":"2024","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117208_b0775","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12943-024-02074-z","article-title":"Circular RNA ACVR2A promotes the progression of hepatocellular carcinoma through mir-511-5p targeting PI3K-akt signaling pathway","volume":"23","author":"Fei","year":"2024","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.bcp.2025.117208_b0780","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41576-023-00645-2","article-title":"RNA modifications in physiology and disease: towards clinical applications","volume":"25","author":"Delaunay","year":"2024","journal-title":"Nat. Rev. Genet."},{"issue":"4","key":"10.1016\/j.bcp.2025.117208_b0785","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.gpb.2022.09.007","article-title":"NSUN2-mediated mRNA m(5)C Modification Regulates the Progression of Hepatocellular Carcinoma","volume":"21","author":"Song","year":"2023","journal-title":"Genomics Proteomics Bioinformatics"},{"issue":"8","key":"10.1016\/j.bcp.2025.117208_b0790","doi-asserted-by":"crossref","first-page":"e1801","DOI":"10.1002\/ctm2.1801","article-title":"A novel peptide encoded by circ-SLC9A6 promotes lipid dyshomeostasis through the regulation of H4K16ac-mediated CD36 transcription in NAFLD","volume":"14","author":"Wang","year":"2024","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.bcp.2025.117208_b0795","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/s41467-023-37142-3","article-title":"Deficiency of gluconeogenic enzyme PCK1 promotes metabolic-associated fatty liver disease through PI3K\/AKT\/PDGF axis activation in male mice","volume":"14","author":"Ye","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2025.117208_b0800","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1186\/s12885-022-10247-6","article-title":"Differential in vitro effects of targeted therapeutics in primary human liver cancer: importance for combined liver cancer","volume":"22","author":"Malik","year":"2022","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.bcp.2025.117208_b0805","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191115","article-title":"Zheng, et al., \u03b2-Catenin induces transcriptional expression of PD-L1 to promote glioblastoma immune evasion","volume":"217","author":"Du","year":"2020","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.bcp.2025.117208_b0810","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/BS9.0000000000000149","article-title":"PD-L1: expression regulation","volume":"5","author":"Zhou","year":"2023","journal-title":"Blood Sci."},{"issue":"14","key":"10.1016\/j.bcp.2025.117208_b0815","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1111\/jcmm.17435","article-title":"Celecoxib attenuates hepatosteatosis by impairing de novo lipogenesis via Akt-dependent lipogenic pathway","volume":"26","author":"Zhang","year":"2022","journal-title":"J. Cell Mol. Med."},{"issue":"Pt A","key":"10.1016\/j.bcp.2025.117208_b0820","article-title":"Anti-hepatitis B virus activity of lithospermic acid, a polyphenol from Salvia miltiorrhiza, in vitro and in vivo by autophagy regulation","volume":"302","author":"Zhu","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bcp.2025.117208_b0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101063","article-title":"Wnt signaling pathway in aging-related tissue fibrosis and therapies","volume":"60","author":"Hu","year":"2020","journal-title":"Ageing Res. Rev."},{"issue":"11","key":"10.1016\/j.bcp.2025.117208_b0830","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70097","article-title":"Chaperonin-containing TCP1 subunit 6A inhibition via TRIM21-mediated K48-linked ubiquitination suppresses triple-negative breast cancer progression through the AKT signalling pathway","volume":"14","author":"Yang","year":"2024","journal-title":"Clin. Transl. Med."},{"issue":"11","key":"10.1016\/j.bcp.2025.117208_b0835","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.13034","article-title":"Kaempferol reduces hepatic triglyceride accumulation by inhibiting Akt","volume":"43","author":"Hoang","year":"2019","journal-title":"J. Food Biochem."},{"issue":"3","key":"10.1016\/j.bcp.2025.117208_b0840","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/carcin\/bgt365","article-title":"[6]-shogaol inhibits growth and induces apoptosis of non-small cell lung cancer cells by directly regulating Akt1\/2","volume":"35","author":"Kim","year":"2014","journal-title":"Carcinogenesis"},{"issue":"9","key":"10.1016\/j.bcp.2025.117208_b0845","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.freeradbiomed.2012.01.026","article-title":"Tehranolide inhibits proliferation of MCF-7 human breast cancer cells by inducing G0\/G1 arrest and apoptosis","volume":"52","author":"Noori","year":"2012","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.bcp.2025.117208_b0850","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20192727","article-title":"Isoliquiritigenin inhibits the proliferation, migration and metastasis of Hep3B cells via suppressing cyclin D1 and PI3K\/AKT pathway","volume":"40","author":"Huang","year":"2020","journal-title":"Biosci. Rep."},{"issue":"9","key":"10.1016\/j.bcp.2025.117208_b0855","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1111\/febs.15112","article-title":"A natural AKT inhibitor swertiamarin targets AKT-PH domain, inhibits downstream signaling, and alleviates inflammation","volume":"287","author":"Zhang","year":"2020","journal-title":"FEBS J."},{"key":"10.1016\/j.bcp.2025.117208_b0860","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104806","article-title":"Akt-targeted therapy as a promising strategy to overcome drug resistance in breast cancer - a comprehensive review from chemotherapy to immunotherapy","volume":"156","author":"Jabbarzadeh Kaboli","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.bcp.2025.117208_b0865","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021359","article-title":"Combined BCL-2 and PI3K\/AKT Pathway Inhibition in KMT2A-Rearranged Acute B-Lymphoblastic Leukemia Cells","volume":"24","author":"Holz","year":"2023","journal-title":"Int. J. Mol. Sci."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225004733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225004733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:27:38Z","timestamp":1762097258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225004733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":173,"alternative-id":["S0006295225004733"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117208","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting AKT to treat liver disease: Opportunities and challenges","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117208","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117208"}}